Insight Inv LLC Pfizer Inc Transaction History

Insight Inv LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 22, 2024	SELL	$26.13 - $33.94 $26,130 - $33,940	-1,000 Reduced 10.29%	8,715 $250,000
Q3 2023 Oct 27, 2023	SELL	$32.09 - $37.51 $23,104 - $27,007	-720 Reduced 6.9%	9,715 $322,000
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $214,191 - $247,814	-5,930 Reduced 36.24%	10,435 $382,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $729,699 - $949,962	-18,525 Reduced 53.1%	16,365 $667,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $4,175 - $5,450	-100 Reduced 0.29%	34,890 $1.79 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $15,316 - $18,697	-350 Reduced 0.99%	34,990 $1.53 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $62,117 - $73,651	-1,335 Reduced 3.64%	35,340 $1.85 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $105,316 - $130,500	-2,302 Reduced 5.91%	36,675 $1.9 Million
Q4 2021 May 09, 2022	BUY	$41.32 - $61.25 $1.61 Million - $2.39 Million	38,977 New	38,977 $2.3 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Insight Inv LLC, based on Form 13F filings with the SEC.

Stay updated on Insight Inv LLC with notifications on news.